Related Experiment Videos
The pathophysiology of migraine: year 2005
M Gabriella Buzzi1, Michael A Moskowitz
1Headache Centre, IRCCS Santa Lucia Foundation, Via Ardeatina 306, I-00179, Rome, Italy. mg.buzzi@hsantalucia.it
The Journal of Headache and Pain
|December 16, 2005
Summary
Migraine involves complex trigeminal pain pathways. Cortical spreading depression may link aura to headache generation, offering insights into migraine pathophysiology.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Migraine pathophysiology involves central and peripheral trigeminal pain pathways.
- Triptans are key therapies targeting 5-HT receptors for migraine pain.
- Nitric oxide and cortical spreading depression (CSD) are implicated in migraine attacks.
Purpose of the Study:
- To explore the role of CSD in linking migraine aura to headache pain.
- To investigate the utility of experimental models in understanding drug efficacy.
- To elucidate the involvement of nitric oxide in migraine pathophysiology.
Main Methods:
- Utilizing experimental neurogenic inflammation models for drug screening.
- Investigating the effects of nitric oxide donors on migraine-like pain.
- Examining the activation of trigeminovascular afferents by CSD in rats.
- Correlating CSD with human migraine aura and headache mechanisms.
Main Results:
- Experimental models provide preliminary data on receptor-targeted drugs.
- Nitric oxide donors can induce migraine-like pain.
- CSD in rats activates trigeminovascular pathways, mimicking headache development.
- Human studies suggest CSD underlies migraine aura.
Conclusions:
- CSD may bridge migraine aura and pain generation via trigeminovascular activation.
- Understanding CSD's role can refine antimigraine drug development.
- Further research into CSD and nitric oxide is crucial for migraine treatment.